trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Neovascularization, Pathologic D009389 39 associated lipids
Adenocarcinoma D000230 166 associated lipids
Breast Neoplasms D001943 24 associated lipids
Neoplasms D009369 13 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Ji Z et al. Integrating genomics and proteomics data to predict drug effects using binary linear programming. 2014 PLoS ONE pmid:25036040
Lv W et al. Histone deacetylase 1 and 3 regulate the mesodermal lineage commitment of mouse embryonic stem cells. 2014 PLoS ONE pmid:25412078
Lu HK et al. Ex vivo response to histone deacetylase (HDAC) inhibitors of the HIV long terminal repeat (LTR) derived from HIV-infected patients on antiretroviral therapy. 2014 PLoS ONE pmid:25409334
Yang W et al. Effect of trichostatin A on gelsolin levels, proteolysis of amyloid precursor protein, and amyloid beta-protein load in the brain of transgenic mouse model of Alzheimer's disease. 2014 Curr Alzheimer Res pmid:25387339
Ying H et al. Pressure overload-induced cardiac hypertrophy response requires janus kinase 2-histone deacetylase 2 signaling. 2014 Int J Mol Sci pmid:25380525
Nishida N et al. Identification of epigenetically inactivated genes in human hepatocellular carcinoma by integrative analyses of methylation profiling and pharmacological unmasking. 2014 Dig Dis pmid:25376292
Xie M et al. Effects of 5-aza-2'-deoxycytidine and trichostatin A on high glucose- and interleukin-1β-induced secretory mediators from human retinal endothelial cells and retinal pigment epithelial cells. 2014 Mol. Vis. pmid:25352747
Xiong J et al. USP22 transcriptional activity is negatively regulated by the histone deacetylase inhibitor trichostatin A. 2014 Mol Med Rep pmid:25323692
Li G et al. Short-chain fatty acids enhance adipocyte differentiation in the stromal vascular fraction of porcine adipose tissue. 2014 J. Nutr. pmid:25320182
Quan H et al. Hepatitis C virus core protein epigenetically silences SFRP1 and enhances HCC aggressiveness by inducing epithelial-mesenchymal transition. 2014 Oncogene pmid:23770846
Lu HG et al. TET1 partially mediates HDAC inhibitor-induced suppression of breast cancer invasion. 2014 Mol Med Rep pmid:25175940
Zohre S et al. Trichostatin A-induced apoptosis is mediated by Kruppel-like factor 4 in ovarian and lung cancer. 2014 Asian Pac. J. Cancer Prev. pmid:25169491
Saini M et al. Trichostatin A alters the expression of cell cycle controlling genes and microRNAs in donor cells and subsequently improves the yield and quality of cloned bovine embryos in vitro. 2014 Theriogenology pmid:25151601
Tomioka T et al. The histone deacetylase inhibitor trichostatin A induces neurite outgrowth in PC12 cells via the epigenetically regulated expression of the nur77 gene. 2014 Neurosci. Res. pmid:25128386
Zhang Q et al. Interferon regulatory factor 8 functions as a tumor suppressor in renal cell carcinoma and its promoter methylation is associated with patient poor prognosis. 2014 Cancer Lett. pmid:25109451
Helm D et al. Ion mobility tandem mass spectrometry enhances performance of bottom-up proteomics. 2014 Mol. Cell Proteomics pmid:25106551
Yoshida T et al. Kruppel-like factor 4 protein regulates isoproterenol-induced cardiac hypertrophy by modulating myocardin expression and activity. 2014 J. Biol. Chem. pmid:25100730
Dubois-Pot-Schneider H et al. Inflammatory cytokines promote the retrodifferentiation of tumor-derived hepatocyte-like cells to progenitor cells. 2014 Hepatology pmid:25098666
Wu TH et al. Melatonin prevents neonatal dexamethasone induced programmed hypertension: histone deacetylase inhibition. 2014 J. Steroid Biochem. Mol. Biol. pmid:25090636
Shi Q et al. [Inhibitory effect of trichostatin A on HepG2 cell proliferation and the mechanisms]. 2014 Nan Fang Yi Ke Da Xue Xue Bao pmid:25057056
Tsuji M et al. Epigenetic regulation of resistance to emotional stress: possible involvement of 5-HT1A receptor-mediated histone acetylation. 2014 J. Pharmacol. Sci. pmid:25048113
Huan YJ et al. Epigenetic modification agents improve genomic methylation reprogramming in porcine cloned embryos. 2014 J. Reprod. Dev. pmid:25047549
Sun G et al. Insights into the lysine acetylproteome of human sperm. 2014 J Proteomics pmid:25038526
Ishihara K Eosinophil cell lines. 2014 Methods Mol. Biol. pmid:24986606
Liu H et al. The Smn-independent beneficial effects of trichostatin A on an intermediate mouse model of spinal muscular atrophy. 2014 PLoS ONE pmid:24984019
Maldonado L et al. An epigenetic marker panel for recurrence risk prediction of low grade papillary urothelial cell carcinoma (LGPUCC) and its potential use for surveillance after transurethral resection using urine. 2014 Oncotarget pmid:24980822
Charni Chaabane S et al. PDGF-D expression is down-regulated by TGFβ in fibroblasts. 2014 PLoS ONE pmid:25280005
Knobloch J et al. Resveratrol attenuates the release of inflammatory cytokines from human bronchial smooth muscle cells exposed to lipoteichoic acid in chronic obstructive pulmonary disease. 2014 Basic Clin. Pharmacol. Toxicol. pmid:23981542
Choi DC et al. MicroRNA-7 protects against 1-methyl-4-phenylpyridinium-induced cell death by targeting RelA. 2014 J. Neurosci. pmid:25232110
Vorrink SU et al. Epigenetic determinants of CYP1A1 induction by the aryl hydrocarbon receptor agonist 3,3',4,4',5-pentachlorobiphenyl (PCB 126). 2014 Int J Mol Sci pmid:25116688
Scholpa NE et al. Epigenetic changes in p21 expression in renal cells after exposure to bromate. 2014 Toxicol. Sci. pmid:25015661
Bartling TR et al. Redox-sensitive gene-regulatory events controlling aberrant matrix metalloproteinase-1 expression. 2014 Free Radic. Biol. Med. pmid:24973648
Busbee PB et al. Natural indoles, indole-3-carbinol and 3,3'-diindolymethane, inhibit T cell activation by staphylococcal enterotoxin B through epigenetic regulation involving HDAC expression. 2014 Toxicol. Appl. Pharmacol. pmid:24200994
Poljak M et al. Class I to III histone deacetylases differentially regulate inflammation-induced matrix metalloproteinase 9 expression in primary amnion cells. 2014 Reprod Sci pmid:24429678
Shin HJ et al. Histone deacetylase classes I and II regulate Kaposi's sarcoma-associated herpesvirus reactivation. 2014 J. Virol. pmid:24227836
Unland R et al. Epigenetic repression of the dopamine receptor D4 in pediatric tumors of the central nervous system. 2014 J. Neurooncol. pmid:24264533
Sun DF et al. Inhibition of mTOR signalling potentiates the effects of trichostatin A in human gastric cancer cell lines by promoting histone acetylation. 2014 Cell Biol. Int. pmid:24030871
Kumafuji M et al. Mediator MED18 subunit plays a negative role in transcription via the CDK/cyclin module. 2014 Genes Cells pmid:24840924
Lee J et al. Therapeutic targeting of epigenetic components in amyotrophic lateral sclerosis (ALS). 2014 Curr. Med. Chem. pmid:25005187
Skoge RH et al. Regulation of SIRT2-dependent α-tubulin deacetylation by cellular NAD levels. 2014 DNA Repair (Amst.) pmid:24814981
Smirnova L et al. MicroRNA profiling as tool for in vitro developmental neurotoxicity testing: the case of sodium valproate. 2014 PLoS ONE pmid:24896083
Meier BC and Wagner BK Inhibition of HDAC3 as a strategy for developing novel diabetes therapeutics. 2014 Epigenomics pmid:24811789
Motevalli A et al. The effect of chemotherapeutic agents on telomere length maintenance in breast cancer cell lines. 2014 Breast Cancer Res. Treat. pmid:24807106
Guo W et al. Aberrant methylation and decreased expression of the TGF-β/Smad target gene FBXO32 in esophageal squamous cell carcinoma. 2014 Cancer pmid:24798237
He G et al. Inhibition of autophagy induced by TSA sensitizes colon cancer cell to radiation. 2014 Tumour Biol. pmid:24122231
Palii CG et al. Trichostatin A enhances vascular repair by injected human endothelial progenitors through increasing the expression of TAL1-dependent genes. 2014 Cell Stem Cell pmid:24792117
Soler E and Grosveld F Targeting epigenetics to speed up repair. 2014 Cell Stem Cell pmid:24792110
Poplutz MK et al. Regulation of the Interleukin-6 gene expression during monocytic differentiation of HL-60 cells by chromatin remodeling and methylation. 2014 Immunobiology pmid:24746556
Rafehi H et al. Vascular histone deacetylation by pharmacological HDAC inhibition. 2014 Genome Res. pmid:24732587
Hassan MK et al. Histone deacetylase inhibitors sensitize lung cancer cells to hyperthermia: involvement of Ku70/SirT-1 in thermo-protection. 2014 PLoS ONE pmid:24728004
Drela K et al. Low oxygen atmosphere facilitates proliferation and maintains undifferentiated state of umbilical cord mesenchymal stem cells in an hypoxia inducible factor-dependent manner. 2014 Cytotherapy pmid:24726658
Zhu XJ et al. Novel tumor-suppressor gene epidermal growth factor-containing fibulin-like extracellular matrix protein 1 is epigenetically silenced and associated with invasion and metastasis in human gastric cancer. 2014 Mol Med Rep pmid:24718752
Tu CY et al. Trichostatin A suppresses EGFR expression through induction of microRNA-7 in an HDAC-independent manner in lapatinib-treated cells. 2014 Biomed Res Int pmid:24707474
Zhang YW et al. Integrated analysis of DNA methylation and mRNA expression profiling reveals candidate genes associated with cisplatin resistance in non-small cell lung cancer. 2014 Epigenetics pmid:24699858
Song BS et al. Valproic acid enhances early development of bovine somatic cell nuclear transfer embryos by alleviating endoplasmic reticulum stress. 2014 Reprod. Fertil. Dev. pmid:23506644
Fang J et al. Epigenetic modulation of neuronal apoptosis and cognitive functions in sepsis-associated encephalopathy. 2014 Neurol. Sci. pmid:23925573
Xie L et al. Histone deacetylase inhibitors trichostatin A and vorinostat inhibit TGFβ2-induced lens epithelial-to-mesenchymal cell transition. 2014 Invest. Ophthalmol. Vis. Sci. pmid:24994865
Bitman M et al. Valproate activates ERK signaling pathway in primary human hepatocytes. 2014 Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub pmid:23073524
Michalak P Evidence for maternal imprinting of 45S ribosomal RNA genes in Xenopus hybrids. 2014 Dev. Genes Evol. pmid:24477594
Uhlenbrock F et al. The NKG2D ligand ULBP2 is specifically regulated through an invariant chain-dependent endosomal pathway. 2014 J. Immunol. pmid:25024379
Sassi Fde A et al. Inhibitory activities of trichostatin a in U87 glioblastoma cells and tumorsphere-derived cells. 2014 J. Mol. Neurosci. pmid:24464841
Li H et al. The histone deacetylase inhibitor trichostatin a promotes totipotency in the male gametophyte. 2014 Plant Cell pmid:24464291
Xiao W et al. Trichostatin A, a histone deacetylase inhibitor, suppresses proliferation and epithelial-mesenchymal transition in retinal pigment epithelium cells. 2014 J. Cell. Mol. Med. pmid:24456602
Oride A et al. Trichostatin A specifically stimulates gonadotropin FSHβ gene expression in gonadotroph LβT2 cells. 2014 Endocr. J. pmid:24430728
Sugimoto K et al. Improving allogeneic islet transplantation by suppressing Th17 and enhancing Treg with histone deacetylase inhibitors. 2014 Transpl. Int. pmid:24410777
Zhu M et al. Histone decacetylase inhibitors prevent mitochondrial fragmentation and elicit early neuroprotection against MPP+. 2014 CNS Neurosci Ther pmid:24351065
Wei G et al. [Functional analysis of Oct4 promoter in Xuhuai goat]. 2014 Yi Chuan pmid:25143277
Xu S et al. Cytostatic and apoptotic effects of DNMT and HDAC inhibitors in endometrial cancer cells. 2014 Curr. Pharm. Des. pmid:23888960
Zou JY and Crews FT Release of neuronal HMGB1 by ethanol through decreased HDAC activity activates brain neuroimmune signaling. 2014 PLoS ONE pmid:24551070
Jin YX et al. Histone deacetylase inhibitor trichostatin A affects porcine oocyte maturation in vitro. 2014 Reprod. Fertil. Dev. pmid:23759302
Guilluy C et al. Isolated nuclei adapt to force and reveal a mechanotransduction pathway in the nucleus. 2014 Nat. Cell Biol. pmid:24609268
Liu J et al. DNA promoter and histone H3 methylation downregulate NGX6 in gastric cancer cells. 2014 Med. Oncol. pmid:24338274
Al-Rayyan N et al. 5-Aza-2-deoxycytidine and trichostatin A increase COUP-TFII expression in antiestrogen-resistant breast cancer cell lines. 2014 Cancer Lett. pmid:24513177
Yang W et al. Trichostatin A increases the levels of plasma gelsolin and amyloid beta-protein in a transgenic mouse model of Alzheimer's disease. 2014 Life Sci. pmid:24486299
Brglez V et al. Secreted phospholipases Aâ‚‚are differentially expressed and epigenetically silenced in human breast cancer cells. 2014 Biochem. Biophys. Res. Commun. pmid:24508801
Smith S et al. Histone deacetylase inhibitors selectively target homology dependent DNA repair defective cells and elevate non-homologous endjoining activity. 2014 PLoS ONE pmid:24466340
Chen HY et al. Histone deacetylase inhibitors trichostatin A and suberoylanilide hydroxamic acid attenuate ventilator-induced lung injury. 2014 Pharmazie pmid:24601225
Kilinc V et al. Do iron chelators increase the antiproliferative effect of trichostatin A through a glucose-regulated protein 78 mediated mechanism? 2014 Tumour Biol. pmid:24622883
Bezecny P Histone deacetylase inhibitors in glioblastoma: pre-clinical and clinical experience. 2014 Med. Oncol. pmid:24838514
Kizuka Y et al. Epigenetic regulation of a brain-specific glycosyltransferase N-acetylglucosaminyltransferase-IX (GnT-IX) by specific chromatin modifiers. 2014 J. Biol. Chem. pmid:24619417
Kumar P et al. Histone deacetylase inhibitors modulate the transcriptional regulation of guanylyl cyclase/natriuretic peptide receptor-a gene: interactive roles of modified histones, histone acetyltransferase, p300, AND Sp1. 2014 J. Biol. Chem. pmid:24451378
Sathe A et al. MicroRNA let-7f: a novel regulator of innate immune response in human endocervical cells. 2014 Am. J. Reprod. Immunol. pmid:24405266
Varol N et al. The epigenetically regulated effects of Wnt antagonists on the expression of genes in the apoptosis pathway in human bladder cancer cell line (T24). 2014 DNA Cell Biol. pmid:24665856
Kondo Y et al. Histone deacetylase inhibitor valproic acid promotes the differentiation of human induced pluripotent stem cells into hepatocyte-like cells. 2014 PLoS ONE pmid:25084468
Wisnieski F et al. Differential expression of histone deacetylase and acetyltransferase genes in gastric cancer and their modulation by trichostatin A. 2014 Tumour Biol. pmid:24668547
Yan YE et al. Prenatal nicotinic exposure suppresses fetal adrenal steroidogenesis via steroidogenic factor 1 (SF-1) deacetylation. 2014 Toxicol. Appl. Pharmacol. pmid:24709674
Cherry KE et al. Identification of Tf1 integration events in S. pombe under nonselective conditions. 2014 Gene pmid:24680781
Yang J et al. PTEN methylation involved in benzene-induced hematotoxicity. 2014 Exp. Mol. Pathol. pmid:24680972
Karki P et al. Yin Yang 1 is a repressor of glutamate transporter EAAT2, and it mediates manganese-induced decrease of EAAT2 expression in astrocytes. 2014 Mol. Cell. Biol. pmid:24469401
Serrat N et al. The response of secondary genes to lipopolysaccharides in macrophages depends on histone deacetylase and phosphorylation of C/EBPβ. 2014 J. Immunol. pmid:24307736
Hou SY et al. Expressions of MAGE-A9 and MAGE-A11 in breast cancer and their expression mechanism. 2014 Arch. Med. Res. pmid:24316396
Reeves ME et al. Evidence that RASSF1C stimulation of lung cancer cell proliferation depends on IGFBP-5 and PIWIL1 expression levels. 2014 PLoS ONE pmid:25007054
Alsarraf O et al. Acetylation: a lysine modification with neuroprotective effects in ischemic retinal degeneration. 2014 Exp. Eye Res. pmid:25064603
Kanski R et al. Histone acetylation in astrocytes suppresses GFAP and stimulates a reorganization of the intermediate filament network. 2014 J. Cell. Sci. pmid:25128567
Hennig D et al. Novel insights into appropriate encapsulation methods for bioactive compounds into polymers: a study with peptides and HDAC inhibitors. 2014 Macromol Biosci pmid:23966296
Mahmud N et al. Differential effects of epigenetic modifiers on the expansion and maintenance of human cord blood stem/progenitor cells. 2014 Biol. Blood Marrow Transplant. pmid:24374212
Holownia A et al. Histone acetylation and arachidonic acid cytotoxicity in HepG2 cells overexpressing CYP2E1. 2014 Naunyn Schmiedebergs Arch. Pharmacol. pmid:24287576
Green BB and Kerr DE Epigenetic contribution to individual variation in response to lipopolysaccharide in bovine dermal fibroblasts. 2014 Vet. Immunol. Immunopathol. pmid:24268632
Sharma A et al. Trichostatin-A modulates claudin-1 mRNA stability through the modulation of Hu antigen R and tristetraprolin in colon cancer cells. 2013 Carcinogenesis pmid:23880304
Munro SK et al. Histone deacetylase inhibition by trichostatin A mitigates LPS induced TNFα and IL-10 production in human placental explants. 2013 Placenta pmid:23623485